<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kwon Y</submitter><funding>United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs</funding><funding>NIA NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>American Chemical Society</funding><funding>Kræftens Bekæmpelse</funding><funding>NCI NIH HHS</funding><funding>Lundbeck Foundation</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>Cancer Prevention and Research Institute of Texas</funding><funding>NIGMS NIH HHS</funding><pagination>432</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9879961</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>The tumor suppressor BRCA2 participates in DNA double-strand break repair by RAD51-dependent homologous recombination and protects stressed DNA replication forks from nucleolytic attack. We demonstrate that the C-terminal Recombinase Binding (CTRB) region of BRCA2, encoded by gene exon 27, harbors a DNA binding activity. CTRB alone stimulates the DNA strand exchange activity of RAD51 and permits the utilization of RPA-coated ssDNA by RAD51 for strand exchange. Moreover, CTRB functionally synergizes with the Oligonucleotide Binding fold containing DNA binding domain and BRC4 repeat of BRCA2 in RPA-RAD51 exchange on ssDNA. Importantly, we show that the DNA binding and RAD51 interaction attributes of the CTRB are crucial for homologous recombination and protection of replication forks against MRE11-mediated attrition. Our findings shed light on the role of the CTRB region in genome repair, reveal remarkable functional plasticity of BRCA2, and help explain why deletion of Brca2 exon 27 impacts upon embryonic lethality.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation.</pubmed_title><pmcid>PMC9879961</pmcid><funding_grant_id>R01 GM136717</funding_grant_id><funding_grant_id>R01 GM141091</funding_grant_id><funding_grant_id>RO1 CA168635</funding_grant_id><funding_grant_id>RR180029</funding_grant_id><funding_grant_id>R01 CA246807</funding_grant_id><funding_grant_id>PO1 CA92584</funding_grant_id><funding_grant_id>R01 ES007061</funding_grant_id><funding_grant_id>F30CA260908</funding_grant_id><funding_grant_id>R35 CA241801</funding_grant_id><funding_grant_id>RO1 ES007061</funding_grant_id><funding_grant_id>R56 ES021454</funding_grant_id><funding_grant_id>P01 CA092584</funding_grant_id><funding_grant_id>R223-2016-8</funding_grant_id><funding_grant_id>R01 CA268641</funding_grant_id><funding_grant_id>BC191160</funding_grant_id><funding_grant_id>R01 CA188347</funding_grant_id><funding_grant_id>RP170345</funding_grant_id><funding_grant_id>R01 CA237286</funding_grant_id><funding_grant_id>R01 CA168635</funding_grant_id><funding_grant_id>F30 CA260908</funding_grant_id><funding_grant_id>R50 CA265315</funding_grant_id><funding_grant_id>R01 CA205224</funding_grant_id><funding_grant_id>T32 AG021890</funding_grant_id><funding_grant_id>T32CA148724</funding_grant_id><funding_grant_id>R01CA246807</funding_grant_id><funding_grant_id>T32 CA148724</funding_grant_id><funding_grant_id>RR210023</funding_grant_id><funding_grant_id>R01 CA23728</funding_grant_id><funding_grant_id>PF-22-034-01-DMC</funding_grant_id><funding_grant_id>R167-A10921-B224</funding_grant_id><funding_grant_id>RP220269</funding_grant_id><pubmed_authors>Badamchi Shabestari A</pubmed_authors><pubmed_authors>Rosner H</pubmed_authors><pubmed_authors>Mazin A</pubmed_authors><pubmed_authors>Selemenakis P</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Mukherjee B</pubmed_authors><pubmed_authors>Sorensen CS</pubmed_authors><pubmed_authors>Rogers CM</pubmed_authors><pubmed_authors>Holloway SP</pubmed_authors><pubmed_authors>Sung P</pubmed_authors><pubmed_authors>Petrosius V</pubmed_authors><pubmed_authors>Singh AK</pubmed_authors><pubmed_authors>Lu L</pubmed_authors><pubmed_authors>Kawale AS</pubmed_authors><pubmed_authors>He Z</pubmed_authors><pubmed_authors>Neal FE</pubmed_authors><pubmed_authors>Joel MZ</pubmed_authors><pubmed_authors>Kwon Y</pubmed_authors><pubmed_authors>Wiese C</pubmed_authors><pubmed_authors>Katz JN</pubmed_authors><pubmed_authors>Burma S</pubmed_authors><pubmed_authors>Hromas R</pubmed_authors></additional><is_claimable>false</is_claimable><name>DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation.</name><description>The tumor suppressor BRCA2 participates in DNA double-strand break repair by RAD51-dependent homologous recombination and protects stressed DNA replication forks from nucleolytic attack. We demonstrate that the C-terminal Recombinase Binding (CTRB) region of BRCA2, encoded by gene exon 27, harbors a DNA binding activity. CTRB alone stimulates the DNA strand exchange activity of RAD51 and permits the utilization of RPA-coated ssDNA by RAD51 for strand exchange. Moreover, CTRB functionally synergizes with the Oligonucleotide Binding fold containing DNA binding domain and BRC4 repeat of BRCA2 in RPA-RAD51 exchange on ssDNA. Importantly, we show that the DNA binding and RAD51 interaction attributes of the CTRB are crucial for homologous recombination and protection of replication forks against MRE11-mediated attrition. Our findings shed light on the role of the CTRB region in genome repair, reveal remarkable functional plasticity of BRCA2, and help explain why deletion of Brca2 exon 27 impacts upon embryonic lethality.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-03-17T15:44:57.675Z</modification><creation>2025-04-04T20:34:47.866Z</creation></dates><accession>S-EPMC9879961</accession><cross_references><pubmed>36702902</pubmed><doi>10.1038/s41467-023-36211-x</doi></cross_references></HashMap>